{
  "id": "VR733937",
  "type": "frq",
  "title": "Omega-3",
  "content": {
    "description": "",
    "question": "Show all your work. Indicate clearly the methods you use, because you will be scored on the correctness of your methods as well as on the accuracy and completeness of your results and explanations.\n\nShow all your work. Indicate clearly the methods you use, because you will be scored on the correctness of your methods as well as on the accuracy and completeness of your results and explanations.\n\nA medical researcher completed a study comparing an omega-<math alttext=\"3\" overflow=\"scroll\"><mn>3</mn></math> fatty acids supplement to a placebo in the treatment of irritability in patients with a certain medical condition. Nineteen patients with the medical condition volunteered to participate in the study. The study was conducted using the following weekly schedule.\n\n<math alttext=\"Week 1:\" overflow=\"scroll\"><munder><mrow><mtext>Week</mtext><mspace width=\"0.4em\"></mspace><mn>1</mn></mrow><mo>̲</mo></munder><mo>:</mo></math> Each patient took a randomly assigned treatment, omega-<math alttext=\"3\" overflow=\"scroll\"><mn>3</mn></math> supplement or placebo.\n\n<math alttext=\"Week 2:\" overflow=\"scroll\"><munder><mrow><mtext>Week</mtext><mspace width=\"0.4em\"></mspace><mn>2</mn></mrow><mo>̲</mo></munder><mo>:</mo></math> The patients did not take either the omega-<math alttext=\"3\" overflow=\"scroll\"> <mn>3</mn> </math> supplement or the placebo. This was necessary to reduce the possibility of any carryover effect from the assigned treatment taken during week <math alttext=\"1\" overflow=\"scroll\"><mn>1</mn></math>.\n\n<math alttext=\"Week 3:\" overflow=\"scroll\"><munder><mrow><mtext>Week</mtext><mspace width=\"0.4em\"></mspace><mn>3</mn></mrow><mo>̲</mo></munder><mo>:</mo></math> Each patient took the treatment, omega-<math alttext=\"3\" overflow=\"scroll\"> <mn>3</mn> </math> supplement or placebo, that they did not take during week <math alttext=\"1\" overflow=\"scroll\"><mn>1</mn></math>.\n\nAt the end of week <math alttext=\"1\" overflow=\"scroll\"><mn>1</mn></math> and week <math alttext=\"3\" overflow=\"scroll\"><mn>3</mn></math>, each patient’s irritability was given a score on a scale of <math alttext=\"0\" overflow=\"scroll\"><mn>0</mn></math> to <math alttext=\"10\" overflow=\"scroll\"><mn>10</mn></math>, with <math alttext=\"0\" overflow=\"scroll\"><mn>0</mn></math> representing no irritability and <math alttext=\"10\" overflow=\"scroll\"><mn>10</mn></math> representing the highest level of irritability.\n\nFor each patient, the two irritability scores and the difference in their scores (placebo minus omega-<math alttext=\"3\" overflow=\"scroll\"><mn>3</mn></math>) were recorded. The results are summarized in the table and boxplots.\n\n<math alttext=\"n\" overflow=\"scroll\"><mi>n</mi></math>\n <math alttext=\"Mean\" overflow=\"scroll\"><mtext>Mean</mtext></math>\n <math alttext=\"Standard Deviation\" overflow=\"scroll\"><mtext>Standard Deviation</mtext></math>\n\nPlacebo\n <math alttext=\"19\" overflow=\"scroll\"><mn>19</mn></math>\n <math alttext=\"5.421\" overflow=\"scroll\"><mn>5.421</mn></math>\n <math alttext=\"2.987\" overflow=\"scroll\"><mn>2.987</mn></math>\n\nOmega-<math alttext=\"3\" overflow=\"scroll\"> <mn>3</mn> </math>\n <math alttext=\"19\" overflow=\"scroll\"><mn>19</mn></math>\n <math alttext=\"3.632\" overflow=\"scroll\"><mn>3.632</mn></math>\n <math alttext=\"1.739\" overflow=\"scroll\"><mn>1.739</mn></math>\n\nDifference (placebo minus omega-<math alttext=\"3\" overflow=\"scroll\"> <mn>3</mn> </math>)\n <math alttext=\"19\" overflow=\"scroll\"><mn>19</mn></math>\n <math alttext=\"1.789\" overflow=\"scroll\"><mn>1.789</mn></math>\n <math alttext=\"2.485\" overflow=\"scroll\"><mn>2.485</mn></math>\n\nThe researcher claims the omega-<math alttext=\"3\" overflow=\"scroll\"><mn>3</mn></math> supplement will decrease the mean irritability score of all patients with the medical condition similar to the volunteers who participated in the study. Is there convincing statistical evidence to support the researcher’s claim at a significance level of <math alttext=\"alpha equals 0.05\" overflow=\"scroll\"><mi>α</mi><mo>=</mo><mn>0.05</mn></math> ? Complete the appropriate inference procedure to support your answer.",
    "image": null,
    "frqParts": [
      {
        "text": "Show all your work. Indicate clearly the methods you use, because you will be scored on the correctness of your methods as well as on the accuracy and completeness of your results and explanations.\n\nShow all your work. Indicate clearly the methods you use, because you will be scored on the correctness of your methods as well as on the accuracy and completeness of your results and explanations.\n\nA medical researcher completed a study comparing an omega-<math alttext=\"3\" overflow=\"scroll\"><mn>3</mn></math> fatty acids supplement to a placebo in the treatment of irritability in patients with a certain medical condition. Nineteen patients with the medical condition volunteered to participate in the study. The study was conducted using the following weekly schedule.\n\n<math alttext=\"Week 1:\" overflow=\"scroll\"><munder><mrow><mtext>Week</mtext><mspace width=\"0.4em\"></mspace><mn>1</mn></mrow><mo>̲</mo></munder><mo>:</mo></math> Each patient took a randomly assigned treatment, omega-<math alttext=\"3\" overflow=\"scroll\"><mn>3</mn></math> supplement or placebo.\n\n<math alttext=\"Week 2:\" overflow=\"scroll\"><munder><mrow><mtext>Week</mtext><mspace width=\"0.4em\"></mspace><mn>2</mn></mrow><mo>̲</mo></munder><mo>:</mo></math> The patients did not take either the omega-<math alttext=\"3\" overflow=\"scroll\"> <mn>3</mn> </math> supplement or the placebo. This was necessary to reduce the possibility of any carryover effect from the assigned treatment taken during week <math alttext=\"1\" overflow=\"scroll\"><mn>1</mn></math>.\n\n<math alttext=\"Week 3:\" overflow=\"scroll\"><munder><mrow><mtext>Week</mtext><mspace width=\"0.4em\"></mspace><mn>3</mn></mrow><mo>̲</mo></munder><mo>:</mo></math> Each patient took the treatment, omega-<math alttext=\"3\" overflow=\"scroll\"> <mn>3</mn> </math> supplement or placebo, that they did not take during week <math alttext=\"1\" overflow=\"scroll\"><mn>1</mn></math>.\n\nAt the end of week <math alttext=\"1\" overflow=\"scroll\"><mn>1</mn></math> and week <math alttext=\"3\" overflow=\"scroll\"><mn>3</mn></math>, each patient’s irritability was given a score on a scale of <math alttext=\"0\" overflow=\"scroll\"><mn>0</mn></math> to <math alttext=\"10\" overflow=\"scroll\"><mn>10</mn></math>, with <math alttext=\"0\" overflow=\"scroll\"><mn>0</mn></math> representing no irritability and <math alttext=\"10\" overflow=\"scroll\"><mn>10</mn></math> representing the highest level of irritability.\n\nFor each patient, the two irritability scores and the difference in their scores (placebo minus omega-<math alttext=\"3\" overflow=\"scroll\"><mn>3</mn></math>) were recorded. The results are summarized in the table and boxplots.\n\n<math alttext=\"n\" overflow=\"scroll\"><mi>n</mi></math>\n <math alttext=\"Mean\" overflow=\"scroll\"><mtext>Mean</mtext></math>\n <math alttext=\"Standard Deviation\" overflow=\"scroll\"><mtext>Standard Deviation</mtext></math>\n\nPlacebo\n <math alttext=\"19\" overflow=\"scroll\"><mn>19</mn></math>\n <math alttext=\"5.421\" overflow=\"scroll\"><mn>5.421</mn></math>\n <math alttext=\"2.987\" overflow=\"scroll\"><mn>2.987</mn></math>\n\nOmega-<math alttext=\"3\" overflow=\"scroll\"> <mn>3</mn> </math>\n <math alttext=\"19\" overflow=\"scroll\"><mn>19</mn></math>\n <math alttext=\"3.632\" overflow=\"scroll\"><mn>3.632</mn></math>\n <math alttext=\"1.739\" overflow=\"scroll\"><mn>1.739</mn></math>\n\nDifference (placebo minus omega-<math alttext=\"3\" overflow=\"scroll\"> <mn>3</mn> </math>)\n <math alttext=\"19\" overflow=\"scroll\"><mn>19</mn></math>\n <math alttext=\"1.789\" overflow=\"scroll\"><mn>1.789</mn></math>\n <math alttext=\"2.485\" overflow=\"scroll\"><mn>2.485</mn></math>\n\nThe researcher claims the omega-<math alttext=\"3\" overflow=\"scroll\"><mn>3</mn></math> supplement will decrease the mean irritability score of all patients with the medical condition similar to the volunteers who participated in the study. Is there convincing statistical evidence to support the researcher’s claim at a significance level of <math alttext=\"alpha equals 0.05\" overflow=\"scroll\"><mi>α</mi><mo>=</mo><mn>0.05</mn></math> ? Complete the appropriate inference procedure to support your answer.",
        "image": "https://assets.learnosity.com/organisations/578/VR733937.g06.svg"
      }
    ]
  },
  "topic": {
    "code": "7.4",
    "text": "7.4: Setting Up a Test for a Population Mean"
  },
  "skill": {
    "code": "Skill 1.E",
    "text": "Skill 1.E: Identify an appropriate inference method for significance tests."
  }
}